Hepatitis C assessment to treatment trial

Not Applicable

Completed

• Conditions: Topic: Primary Care; Subtopic: Primary care; Disease: All Diseases; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN61788850
• Lead Sponsor: niversity of Bristol (UK)

Brief Summary

2016 protocol in http://www.ncbi.nlm.nih.gov/pubmed/27473371 2020 results in https://www.ncbi.nlm.nih.gov/pubmed/32094220 (added 26/02/2020) 2020 cost-effectiveness results in https://www.ncbi.nlm.nih.gov/pubmed/32102782 (added 10/03/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-04-24
• Study Completion: 2017-12-31
• Last Update Posted: 30 March 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 920

Inclusion Criteria

For patient interviews:
1. Individuals approached by their GP for a HCV test in participating intervention practices who are aged over 18 years old
2. Able to provide informed consent and who have a telephone they can be contacted on

Exclusion Criteria

For the patient interviews:
Unable to provide informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber/proportion of patients tested for HCV; Timepoint(s): 12 months

Secondary Outcome Measures

Name	Time	Method
<br> 1. Cost of case finding and testing; Timepoint(s): 12 months<br> 2. Incremental cost per case detected; Timepoint(s): 12 months<br> 3. Number and proportion testing positive (yield); Timepoint(s): 12 months<br> 4. Number/ proportion attending for assessment; Timepoint(s): 12 months<br> 5. Number/ proportion initiating treatment; Timepoint(s): 12 months<br> 6. Number/ proportion referred for specialist assessment; Timepoint(s): 12 months<br>